| Dr David L Koppein Jr, NP | |
|
1103 College Dr, Mena, AR 71953-2519 | |
| (479) 394-1414 | |
| (479) 437-3786 |
| Full Name | Dr David L Koppein Jr |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 13 Years |
| Location | 1103 College Dr, Mena, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790988319 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 3167-033 (Wisconsin) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | A004598 (Arkansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mena Family Health Center | 3971629155 | 5 |
| Mena Hospital Commission | 8527057678 | 13 |
News Archive
New research from Japan brings hope of a new treatment for asthma patients resistant to corticosteroids. In a study published today in the journal Nature Communications, researchers from the RIKEN Center for Integrative Medical Sciences and Keio University in Japan report that a type of lymphocytes called natural helper ells plays a critical role in corticosteroid resistance and demonstrate that the anti-psychotic drug Pimozide can be used to overcome resistance to steroids in severe asthma patients.
Agitation and aggression, among others, known as behavioral and psychological symptoms, are hallmarks of Alzheimer's disease and related disorders.
Researchers at the University of Southampton together with colleagues at King's College London have embarked on a unique study that will shed new light on the risk of heart disease and diabetes in later life.
Mylan Inc. today announced that it has launched Olanzapine Orally Disintegrating Tablets (ODT), 5 mg, 10 mg, 15 mg and 20 mg, the generic version of Eli Lilly and Company's Zyprexa Zydis Tablets.
› Verified 6 days ago
| Entity Name | Mena Hospital Commission |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285739581 PECOS PAC ID: 8527057678 Enrollment ID: O20040512000557 |
News Archive
New research from Japan brings hope of a new treatment for asthma patients resistant to corticosteroids. In a study published today in the journal Nature Communications, researchers from the RIKEN Center for Integrative Medical Sciences and Keio University in Japan report that a type of lymphocytes called natural helper ells plays a critical role in corticosteroid resistance and demonstrate that the anti-psychotic drug Pimozide can be used to overcome resistance to steroids in severe asthma patients.
Agitation and aggression, among others, known as behavioral and psychological symptoms, are hallmarks of Alzheimer's disease and related disorders.
Researchers at the University of Southampton together with colleagues at King's College London have embarked on a unique study that will shed new light on the risk of heart disease and diabetes in later life.
Mylan Inc. today announced that it has launched Olanzapine Orally Disintegrating Tablets (ODT), 5 mg, 10 mg, 15 mg and 20 mg, the generic version of Eli Lilly and Company's Zyprexa Zydis Tablets.
› Verified 6 days ago
| Entity Name | Mena Family Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447571047 PECOS PAC ID: 3971629155 Enrollment ID: O20100924000616 |
News Archive
New research from Japan brings hope of a new treatment for asthma patients resistant to corticosteroids. In a study published today in the journal Nature Communications, researchers from the RIKEN Center for Integrative Medical Sciences and Keio University in Japan report that a type of lymphocytes called natural helper ells plays a critical role in corticosteroid resistance and demonstrate that the anti-psychotic drug Pimozide can be used to overcome resistance to steroids in severe asthma patients.
Agitation and aggression, among others, known as behavioral and psychological symptoms, are hallmarks of Alzheimer's disease and related disorders.
Researchers at the University of Southampton together with colleagues at King's College London have embarked on a unique study that will shed new light on the risk of heart disease and diabetes in later life.
Mylan Inc. today announced that it has launched Olanzapine Orally Disintegrating Tablets (ODT), 5 mg, 10 mg, 15 mg and 20 mg, the generic version of Eli Lilly and Company's Zyprexa Zydis Tablets.
› Verified 6 days ago
| Entity Name | Walk In Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699096297 PECOS PAC ID: 8022134261 Enrollment ID: O20100925000017 |
News Archive
New research from Japan brings hope of a new treatment for asthma patients resistant to corticosteroids. In a study published today in the journal Nature Communications, researchers from the RIKEN Center for Integrative Medical Sciences and Keio University in Japan report that a type of lymphocytes called natural helper ells plays a critical role in corticosteroid resistance and demonstrate that the anti-psychotic drug Pimozide can be used to overcome resistance to steroids in severe asthma patients.
Agitation and aggression, among others, known as behavioral and psychological symptoms, are hallmarks of Alzheimer's disease and related disorders.
Researchers at the University of Southampton together with colleagues at King's College London have embarked on a unique study that will shed new light on the risk of heart disease and diabetes in later life.
Mylan Inc. today announced that it has launched Olanzapine Orally Disintegrating Tablets (ODT), 5 mg, 10 mg, 15 mg and 20 mg, the generic version of Eli Lilly and Company's Zyprexa Zydis Tablets.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David L Koppein Jr, NP 10000 W Innovation Dr, Milwaukee, WI 53226-4837 Ph: (414) 456-5006 | Dr David L Koppein Jr, NP 1103 College Dr, Mena, AR 71953-2519 Ph: (479) 394-1414 |
News Archive
New research from Japan brings hope of a new treatment for asthma patients resistant to corticosteroids. In a study published today in the journal Nature Communications, researchers from the RIKEN Center for Integrative Medical Sciences and Keio University in Japan report that a type of lymphocytes called natural helper ells plays a critical role in corticosteroid resistance and demonstrate that the anti-psychotic drug Pimozide can be used to overcome resistance to steroids in severe asthma patients.
Agitation and aggression, among others, known as behavioral and psychological symptoms, are hallmarks of Alzheimer's disease and related disorders.
Researchers at the University of Southampton together with colleagues at King's College London have embarked on a unique study that will shed new light on the risk of heart disease and diabetes in later life.
Mylan Inc. today announced that it has launched Olanzapine Orally Disintegrating Tablets (ODT), 5 mg, 10 mg, 15 mg and 20 mg, the generic version of Eli Lilly and Company's Zyprexa Zydis Tablets.
› Verified 6 days ago
Terri L Barrada, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 136 Health Park Dr, Mena, AR 71953 Phone: 888-710-8220 Fax: 866-573-0761 | |
Gretchen Laurel Goodnight, ANP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 403 Morrow St N Ste D, Mena, AR 71953 Phone: 479-437-6080 Fax: 479-437-6079 | |
Lindy Kaye Jumper, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 136 Health Park Dr, Mena, AR 71953 Phone: 888-710-8220 Fax: 866-573-0761 | |
Kimberly Diane Nance, APRN, BC, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1706 Highway 71 N, Mena, AR 71953 Phone: 479-394-4800 Fax: 479-394-4805 | |
Ocean Miranda Brewer, APRN-CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1210 Dequeen St, Mena, AR 71953 Phone: 479-394-5068 Fax: 479-394-5626 | |
Sandy Morgan, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1706 Highway 71 N, Mena, AR 71953 Phone: 479-394-1500 Fax: 479-394-1525 | |
Mrs. Debra Inevia Fairless, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1210 Dequeen St, Mena, AR 71953 Phone: 479-394-5068 Fax: 479-394-5626 |